ABOUT US

New Day Diagnostics (NDDx) is pioneering the future of healthcare diagnostics, empowering patients, providers, and researchers through innovation. With our rapidly expanding portfolio—spanning New Day Bioresearch, ColoHealth™ blood-based colorectal cancer screening, and a robust pipeline of diagnostic solutions—we are positioned to become a global leader in early detection of disease. Our mission is to make health information more accessible, accelerating the path from discovery to diagnosis when it is most critical to improving patient care and outcomes.

Through New Day Bioresearch, we provide comprehensive support for assay design, analytical validation, clinical performance evaluation, and regulatory compliance, helping our partners and Sponsors bring new products to market faster and more efficiently. Whether driving advancements in oncology, infectious diseases, gastrointestinal disorders, or women’s health, our specialized ISO13485:2016 Design and Development laboratories and high-complexity CLIA services deliver unmatched quality.

As we evolve, New Day Diagnostics aims to revolutionize personalized medicine with state-of-the-art multiomic technologies, such as ColoPlexPLUS™ and companion diagnostics for pharmaceuticals and biologics. Our team combines scientific expertise with operational excellence, ensuring accelerated study timelines, enhanced data quality, and optimal patient-centric study designs.

Together with our strategic partnerships and global reach, New Day Diagnostics stands at the intersection of technology and healthcare, delivering innovative, patient-centric solutions. By bridging the gap between the lab, bedside, and home, we are transforming early detection diagnostics and unlocking the future of preventive care.

Executive Team

Eric Mayer, MS, MBA

Chief Executive Officer

Jason Liggett, PhD

Chief Scientific Officer

Suzanne Lee

Chief Operating Officer

Medical Advisors

Melissa Chiles, MD

Medical Director

Danielle Gibson, MD

Physician on Record

Mark Harmon, MD

Medical Affairs Consultant

Board of Directors

Navroze Mehta

Eric Mayer

David Allyn

Chris Chandler

William C. Kouns

Autumn Anfang

Scott Gucciardi

SCIENTIFIC ADVISORY BOARD

Bergein Overholt, M.D.

Herbert A. Fritsche, PhD

Our Location

New Day Diagnostics is proudly located at the University of Tennessee Research Park at Cherokee Farm, just across the Tennessee River from UT’s flagship Knoxville campus. Our proximity allows us to collaborate with UT’s cutting-edge research, experts at the University of Tennessee Medical Center, and researchers in advanced materials, future mobility, energy, artificial intelligence, and human health and wellness providing us with unique opportunities to drive innovation in diagnostic solutions.